FGFR is the most common fusion expressed in GBM, specifically fibroblast growth factor receptor 3–transforming acidic coiled coil-containing protein 3 (FGFR3:TACC3), which is the fusion with relevance as a potential target in multiple cancers, including GBM [33]. This evidence concerns the gene TACC3 and glioblastoma.